As more states legalize medical marijuana, two key groups—researchers whose job is it to understand its benefits and drawbacks, and physicians charged with advising potential users—are struggling to catch up with policymakers. Ilana Braun, an assistant professor of psychiatry at Harvard Medical School and chief of the division of adult psychosocial oncology at the Dana-Farber